275 related articles for article (PubMed ID: 9466018)
1. Protamine dosing--the quandary continues.
Hall RI
Can J Anaesth; 1998 Jan; 45(1):1-5. PubMed ID: 9466018
[No Abstract] [Full Text] [Related]
2. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
Shore-Lesserson L; Reich DL; DePerio M
Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
[TBL] [Abstract][Full Text] [Related]
3. [Cardiopulmonary bypass and blood coagulation].
Kitaguchi K; Furuie H
Masui; 2001 Dec; 50 Suppl():S115-20. PubMed ID: 11871083
[No Abstract] [Full Text] [Related]
4. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review.
Boer C; Meesters MI; Veerhoek D; Vonk ABA
Br J Anaesth; 2018 May; 120(5):914-927. PubMed ID: 29661409
[TBL] [Abstract][Full Text] [Related]
5. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
Khan NU; Wayne CK; Barker J; Strang T
Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
[TBL] [Abstract][Full Text] [Related]
6. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
7. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
[TBL] [Abstract][Full Text] [Related]
8. Safety issues in heparin and protamine administration for extracorporeal circulation.
Jobes DR
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
[TBL] [Abstract][Full Text] [Related]
9. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
10. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
Levin AI; Heine AM; Coetzee JF; Coetzee A
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro.
Ho LTS; McVey MJ; Kuiper GJAJM; Gross PL; Karkouti K
Br J Anaesth; 2021 Oct; 127(4):e128-e130. PubMed ID: 34334192
[No Abstract] [Full Text] [Related]
12. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F
PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705
[TBL] [Abstract][Full Text] [Related]
13. Extreme Plasma Dilution Decreases Heparin and Protamine Cardiopulmonary Bypass Requirements: A Case Report on a Jehovah's Witness Patient.
Chang E; Gatling JW; Bode S; Herrmann PC; Bull BS; Applegate RL
A A Case Rep; 2017 Jun; 8(11):291-293. PubMed ID: 28328588
[TBL] [Abstract][Full Text] [Related]
14. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
Peterson JA; Maroney SA; Zwifelhofer W; Wood JP; Yan K; Bercovitz RS; Woods RK; Mast AE
J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
[TBL] [Abstract][Full Text] [Related]
15. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass.
Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC
Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140
[TBL] [Abstract][Full Text] [Related]
16. Management of postoperative heparin rebound following cardiopulmonary bypass.
Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
[TBL] [Abstract][Full Text] [Related]
17. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
18. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
19. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
[TBL] [Abstract][Full Text] [Related]
20. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
El Rouby S; Rinehart K; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]